Cosmo Technologies Ltd
12 clinical trials · Sponsor
◉ Watch Cosmo Technologies Ltd
| Record | Firm | Date |
|---|---|---|
| Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D (NCT03099785) | Cosmo Technologies Ltd | 2017-12-18 |
Track Cosmo Technologies Ltd automatically
Every clearance here is in the API, with alerts when new ones post.